Advances in acute myeloid leukemia classification, prognostication and monitoring by flow cytometry
F Lucas, CB Hergott - Clinics in Laboratory Medicine, 2023 - labmed.theclinics.com
The categorization of acute myeloid leukemia (AML) into subsets with specific biological
characteristics and clinical outcomes is guided by morphologic, cytogenetic, and molecular …
characteristics and clinical outcomes is guided by morphologic, cytogenetic, and molecular …
The clinicogenomic landscape of induction failure in childhood and young adult T-cell acute lymphoblastic leukemia
PURPOSE Failure to respond to induction chemotherapy portends a poor outcome in
childhood acute lymphoblastic leukemia (ALL) and is more frequent in T-cell ALL (T-ALL) …
childhood acute lymphoblastic leukemia (ALL) and is more frequent in T-cell ALL (T-ALL) …
[HTML][HTML] Fatal outcome of a rare acute myeloid leukemia with t (8; 16)(p11. 2; p13. 3) and KAT6A:: CREBBP gene fusion in a young man
A Spałek, A Bartkowska-Chrobok… - … , Transfusion and Cell …, 2024 - Elsevier
Acute myeloid leukemia (AML) with t (8; 16)(p11; p13)/KAT6A:: CREBBP is a very rare
condition that accounts for less than 0.1% of de novo AML cases. 1 According to the …
condition that accounts for less than 0.1% of de novo AML cases. 1 According to the …
De novo monocytic-M5b AML with t (8; 16)(p11. 2; p13. 3) KAT6A/CREBBP fusion and FLT3-TKD mutation complicated by chemotherapy-induced Takotsubo …
A Ananthaneni, T Benzar, N Hafiz… - BMJ Case Reports …, 2023 - casereports.bmj.com
Acute myeloid leukemia (AML) with t (8; 16) is a rare cytogenetic abnormality that presents
unique characteristics such as hemophagocytosis, disseminated intravascular coagulation …
unique characteristics such as hemophagocytosis, disseminated intravascular coagulation …
[引用][C] Monitoring KAT6A-CREBBP measurable residual disease in t (8; 16) therapy-related acute myeloid leukemia.
Ú Bhreathnach, D Doherty, K Murphy, CM Flynn… - Leukemia …, 2022 - europepmc.org
Monitoring KAT6A-CREBBP measurable residual disease in t(8;16) therapy-related acute
myeloid leukemia. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …
myeloid leukemia. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …